Reata Pharmaceuticals Inc (NASDAQ:RETA)

39.64
Delayed Data
As of 4:00pm ET
 +0.66 / +1.69%
Today’s Change
18.47
Today|||52-Week Range
76.20
+50.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues7.6M5.2M8.5M7.8M
 
 
 
 
 
Depreciation And Amortization105.0K105.0K120.0K170.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses34.1M34.6M33.3M36.2M
 
 
 
 
 
Research And Development23.4M27.1M25.3M26.1M
 
 
 
 
 
Total Operating Expenses34.2M34.7M33.4M36.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.7M-29.6M-24.9M-28.6M
 
 
 
 
 
Extraordinary Charge-1.0M0.000.000.00
 
 
Interest Expense On Debt903.0K2.4M2.4M2.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-28.2M-30.8M-25.6M-29.2M
 
 
 
 
 
Income Taxes-6.0K-9.0K-11.0K-2.0K
 
 
 
 
 
Net Income-28.2M-30.8M-25.6M-29.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS26.2M28.7M29.7M29.8M
 
 
 
 
 
Shares To Calculate EPS Diluted26.2M28.7M29.7M29.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.08-$1.07-$0.86-$0.98
 
 
 
 
 
EPS Diluted-$1.08-$1.07-$0.86-$0.98